%0 Journal Article
%T Tratamiento de anemia con eritropoyetina humana recombinante durante el embarazo en el trasplante renal
%A Gerardo Borroto D赤az
%A Carlos Guerrero D赤az
%A Malicela Barcel車 Acosta
%A Pedro Ponce P谷rez
%J Revista Cubana de Medicina
%D 2003
%I ECIMED
%X Se present車 el caso de una paciente de 24 a os de edad y raza blanca con antecedentes de nefritis t迆bulo-intersticial cr車nica, por lo cual llega a la insuficiencia renal cr車nica grado IV. Se mantuvo 2 a os en m谷todos dial赤ticos, recibi車 un trasplante renal de donante vivo y, 3 a os despu谷s, con cierto deterioro de la funci車n renal se le diagnostic車 un embarazo de 20 sem con una anemia severa multifactorial. Se le indic車 tratamiento con eritropoyetina humana recombinante, de fabricaci車n nacional, a dosis de 50 kg/2 veces por semana hasta un mes despu谷s del parto. Se logr車 una evoluci車n satisfactoria del embarazo y la funci車n del trasplante renal sin aparici車n de efectos secundarios en la madre ni el reci谷n nacido. The case of a 24-year-old white female patient with history of chronic tubulointerstitial nephritis that led her to chronic renal failure grade IV was reported. Dyalitic methods were used for 2 years and she received a kidney transplant from a live donor. 3 years later, with some deterioration of the renal function, she was diagnosed a pregnancy of 20 weeks with a severe multifactorial anemia. Treatment with Cuban human recombinant erythropoietin was indicated at doses of 50 ukg twice a week up to a month after delivery. A satisfactory evolution of pregnancy was attained and the function of the kidney transplant had no secondary effects either in the mother or in the newborn infant.
%K ERITROPOYETINA RECOMBINANTE
%K ANEMIA
%K EMBARAZO
%K INSUFICIENCIA RENAL CRONICA
%K ERYTHROPOIETIN
%K RECOMBINANT
%K ANEMIA
%K PREGNANCY
%K KIDNEY FAILURE
%K CHRONIC
%U http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232003000100012